Elevate Ant™
DeviceSurgery with Elevate Ant™
NCT Number: NCT03187574
Our study is a non-randomized prospective study compared two groups matched for anterior/apical POP-Q grade: 84 received Elevate Ant™ single-incision mesh (group A) and 42 Perigee™ transvaginal mesh (group B). The study hypothesis was that the Elevate Ant™ mesh would provide better apical correction than the Perigee™ mesh. One- and 2-year follow-up comprised anatomic assessment (POP-Q) and QoL (PFDI-20, PFIQ-7, PISQ-12). Success was defined as 2-year POP-Q ≤1. Secondary endpoints were function and complications.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Surgery with Elevate Ant™
Surgery with Perigee™
Time frame: 1 year post-surgery
Hospices Civils de Lyon
Other
A Prospective Comparison of Two Vaginal Mesh Kits in the Management of Anterior and Apical Vaginal Prolapse: Long Term-results for Apical Fixation and Quality of Life
Acronym: ELEPE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07554651
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Dnipro, Ukraine
View Trial DetailsNCT05463081
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Tver', Tver Oblast, Russia
View Trial DetailsNCT03658395
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT02431897
Cystocele, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial Details